Literature DB >> 27621430

Defining the potential antidepressant mode of action of acetyl-l-carnitine.

Arduino Arduini1, Mario Bonomini2, Victor Zammit3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27621430      PMCID： PMC5047158          DOI： 10.1073/pnas.1612025113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  10 in total

1.  Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance.

Authors:  Benedetta Bigio; Aleksander A Mathé; Vasco C Sousa; Danielle Zelli; Per Svenningsson; Bruce S McEwen; Carla Nasca
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-27       Impact factor: 11.205

2.  Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation.

Authors:  Padma Madiraju; Shri V Pande; Marc Prentki; S R Murthy Madiraju
Journal:  Epigenetics       Date:  2009-08-18       Impact factor: 4.528

3.  A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation.

Authors:  Gopinath Sutendra; Adam Kinnaird; Peter Dromparis; Roxane Paulin; Trevor H Stenson; Alois Haromy; Kyoko Hashimoto; Nancy Zhang; Eric Flaim; Evangelos D Michelakis
Journal:  Cell       Date:  2014-07-03       Impact factor: 41.582

4.  Depression and poor glycemic control: a meta-analytic review of the literature.

Authors:  P J Lustman; R J Anderson; K E Freedland; M de Groot; R M Carney; R E Clouse
Journal:  Diabetes Care       Date:  2000-07       Impact factor: 19.112

5.  L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors.

Authors:  Carla Nasca; Dionysios Xenos; Ylenia Barone; Alessandra Caruso; Sergio Scaccianoce; Francesco Matrisciano; Giuseppe Battaglia; Aleksander A Mathé; Anna Pittaluga; Luana Lionetto; Maurizio Simmaco; Ferdinando Nicoletti
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 6.  Carnitine, mitochondrial function and therapy.

Authors:  Victor A Zammit; Rona R Ramsay; Mario Bonomini; Arduino Arduini
Journal:  Adv Drug Deliv Rev       Date:  2009-08-26       Impact factor: 15.470

Review 7.  Carnitine in metabolic disease: potential for pharmacological intervention.

Authors:  Arduino Arduini; Mario Bonomini; Vincenzo Savica; Antonino Amato; Victor Zammit
Journal:  Pharmacol Ther       Date:  2008-08-31       Impact factor: 12.310

8.  Effects of L-carnitine and its acetate and propionate esters on the molecular dynamics of human erythrocyte membrane.

Authors:  A Arduini; N Gorbunov; E Arrigoni-Martelli; S Dottori; F Molajoni; F Russo; G Federici
Journal:  Biochim Biophys Acta       Date:  1993-03-14

9.  Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.

Authors:  Sean H Adams; Charles L Hoppel; Kerry H Lok; Ling Zhao; Scott W Wong; Paul E Minkler; Daniel H Hwang; John W Newman; W Timothy Garvey
Journal:  J Nutr       Date:  2009-04-15       Impact factor: 4.798

10.  Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility.

Authors:  Deborah M Muoio; Robert C Noland; Jean-Paul Kovalik; Sarah E Seiler; Michael N Davies; Karen L DeBalsi; Olga R Ilkayeva; Robert D Stevens; Indu Kheterpal; Jingying Zhang; Jeffrey D Covington; Sudip Bajpeyi; Eric Ravussin; William Kraus; Timothy R Koves; Randall L Mynatt
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287
  10 in total
  1 in total

1.  Reply to Arduini et al.: Acetyl-l-carnitine and the brain: Epigenetics, energetics, and stress.

Authors:  Benedetta Bigio; Carla Nasca; Bruce S McEwen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.